Urolithin A preserves renal perfusion and function and attenuates inflammasome-associated signaling in a translational porcine model of sepsis-induced acute kidney injury

Sepsis is a life-threatening reaction where the body's own defense system turns against itself in response to an infection. It is a medical emergency that can strike anyone, but it carries a particularly heavy toll on the kidneys. When sepsis occurs, it often triggers acute kidney injury, a sudden failure of the organs that filter waste from the blood. This complication is common, affecting up to six out of ten people with severe sepsis, and it drastically increases the risk of death or long-term kidney disease. Currently, doctors treat the infection with antibiotics and support the patient with fluids and blood pressure medications, but there is no specific medicine designed to stop the kidney damage itself. The damage happens through a complex mix of poor blood flow, inflammation, and a specific type of cellular self-destruction that releases harmful chemicals, overwhelming the organ's ability to function.

Researchers have long looked for ways to interrupt this destructive cycle. One promising candidate is a substance called urolithin A. This is not a drug synthesized in a lab from scratch, but a natural compound produced by the human gut when it breaks down certain plant foods like pomegranates, walnuts, and berries. In earlier studies on smaller animals, urolithin A showed signs of being able to calm inflammation and protect cells from stress. However, it remained unknown whether this substance could actually preserve kidney function during a full-blown septic crisis in a large animal that closely mimics human physiology. To find out, a team of scientists turned to a model that bridges the gap between a mouse and a human: the pig.

The researchers set up a controlled experiment using young male pigs, a species chosen because their size and organ systems are remarkably similar to ours. They divided the animals into groups to test the effects of a severe infection. One group served as a control, receiving only sterile salt water. The other groups were subjected to fecal peritonitis, a condition created by introducing their own fresh fecal material into the abdominal cavity. This mimics a real-world scenario where a bowel perforation allows gut bacteria to spill into the body, triggering a massive, uncontrolled infection. In the treated group, the pigs received an intravenous dose of urolithin A shortly after the infection was induced, while the untreated infected group received a placebo. The team then monitored the animals for twenty-four hours, a critical window where the body's response to sepsis can either stabilize or spiral into organ failure.

The results painted a clear picture of what happens when sepsis strikes and how urolithin A changes the outcome. In the untreated pigs, the infection caused a rapid decline in health. Their blood pressure dropped significantly, their hearts pumped less blood, and the flow of blood to the kidneys slowed to a trickle. This lack of circulation meant the kidneys could not filter waste effectively, leading to a sharp rise in markers of kidney injury in the blood and urine. The organs were under immense stress, with high levels of oxidative damage and inflammation. In contrast, the pigs that received urolithin A fared much better. Their blood pressure remained higher, their hearts maintained a stronger output, and crucially, blood flow to the kidneys was preserved. The treated animals kept their kidneys filtering waste at a near-normal rate, and the levels of injury markers in their bodies were significantly lower than in the untreated group.

Digging deeper into the tissue, the scientists found that the protection offered by urolithin A was linked to how it handled the cellular machinery of inflammation. Sepsis triggers a specific alarm system inside cells known as the inflammasome. When this system is overactivated, it causes cells to burst open in a violent process called pyroptosis, releasing a flood of inflammatory signals that damage surrounding tissue. In the untreated pigs, the kidneys were full of active inflammasomes and the broken fragments of cells that result from this process. The treated pigs, however, showed a marked reduction in these signals. The urolithin A appeared to calm the inflammasome, preventing the cells from undergoing this destructive self-destruction and keeping the inflammatory response in check.

To confirm that this effect happened directly within the kidney cells, the researchers also tested the substance in a dish using pig kidney cells exposed to bacterial toxins. When these cells were challenged, they showed the same signs of stress and inflammasome activation seen in the sick animals. Adding urolithin A to the mix reduced the activity of the enzymes responsible for the cell bursting and lowered the levels of the inflammatory proteins. This confirmed that the substance could act directly on the kidney tissue to blunt the specific molecular pathways that drive injury during sepsis.

The study highlights a significant step forward in understanding how to protect the kidneys during critical illness. While the treated pigs did not show severe structural damage to their kidneys after just twenty-four hours, the physiological data showed that their organs were functioning much better than those of the untreated animals. The researchers noted that the benefits seen in the treated group were likely a combination of improved overall blood flow and a direct protective effect on the kidney cells themselves. Because the pigs did not receive antibiotics or advanced life support beyond basic fluids, the experiment modeled the early stages of the disease rather than a fully managed clinical case.

This work suggests that urolithin A could be a valuable tool for preserving kidney function when sepsis strikes, but it is not yet a cure. The substance showed promise in a large animal model that closely resembles human physiology, demonstrating that it can maintain blood flow, reduce inflammation, and stop the specific type of cell death that damages the kidneys. The findings provide a strong reason to investigate this natural compound further, particularly to see if it can be used alongside standard medical care to prevent kidney failure in patients with severe infections. For now, the research offers a hopeful glimpse into a potential future where a simple, naturally derived molecule helps the body survive one of its most dangerous internal battles.